On May 29, 2014, Beasley Broadcast Group Inc (NASDAQ:BBGI), a large- and mid-size market radio broadcaster, announced today that its Board of Directors declared a quarterly cash dividend of $0.045 per share of its Class A and Class B common stock. The dividend is payable on July 10, 2014, to shareholders of record on June 30, 2014. Beasley Broadcast Group Inc (NASDAQ:BBGI), net profit margin is 11.10% and weekly performance is -0.85%. On last trading day company shares ended up $6.99. Analysts mean target price for the company is $1.50. Beasley Broadcast Group Inc (NASDAQ:BBGI), distance from 50-day simple moving average (SMA50) is -13.38%.
Transgenomic Inc (NASDAQ:TBIO), major shareholder Leroy C. Kopp sold 413,050 shares of Transgenomic stock in a transaction dated Thursday, May 22nd. The shares were sold at an average price of $3.70, for a total value of $1,528,285.00. Transgenomic Inc (NASDAQ:TBIO), fell 6.58% in last trading session and ended the day on $3.69. TBIO, Gross Margin is 45.50% and its return on assets is -46.80%. Transgenomic Inc (NASDAQ:TBIO), quarterly performance is -28.35%.
Video Display Corporation (NASDAQ:VIDE), shares moved down 2.14% in last trading session and was closed at $3.27, while trading in range of $3.01 – 3.34. Video Display Corporatio (NASDAQ:VIDE), year to date (YTD) performance is -7.37%.
Education Management Corp (NASDAQ:EDMC)‘s stock had its “market perform” rating restated by equities researchers at BMO Capital Markets in a research report issued on Monday, AnalystRatings.Netreports. They currently have a $3.00 price objective on the stock, down from their previous price objective of $5.00. BMO Capital Markets’ target price indicates a potential upside of 1.35% from the company’s current price. Education Management Corp (NASDAQ:EDMC), ended the last trading day at $1.87. Company weekly volatility is calculated as 6.61% and price to cash ratio as 3.87. Education Management Corp (NASDAQ:EDMC), showed a negative weekly performance of 2.60%.
On May 28, 2014, Transgenomic Inc (NASDAQ:TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, announced that it has signed a license with the Dana-Farber Cancer Institute for worldwide rights to develop and commercialize multiplexed versions of its ICE COLD-PCR technology (MX ICE COLD-PCR). Transgenomic Inc (NASDAQ:TBIO), net profit margin is -61.50% and weekly performance is -1.60%. On last trading day company shares ended up $3.69. Analysts mean target price for the company is $10.00. Transgenomic Inc (NASDAQ:TBIO), distance from 50-day simple moving average (SMA50) is -15.34%.
Leave a Reply